-
1
-
-
65449123539
-
Differentiating intestinal tuberculosis from Crohn's disease: A diagnostic challenge
-
Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009;104:1003-12.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1003-1012
-
-
Almadi, M.A.1
Ghosh, S.2
Aljebreen, A.M.3
-
2
-
-
77949273279
-
Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis
-
Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol 2010;105:642-51.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 642-651
-
-
Makharia, G.K.1
Srivastava, S.2
Das, P.3
-
3
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
-
Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Keane, J.1
Gershon, S.2
Wise, R.P.3
-
4
-
-
0037231533
-
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
-
DOI 10.1002/art.10697
-
Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45. (Pubitemid 36091645)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.1
, pp. 35-45
-
-
Weinblatt, M.E.1
Keystone, E.C.2
Furst, D.E.3
Moreland, L.W.4
Weisman, M.H.5
Birbara, C.A.6
Teoh, L.A.7
Fischkoff, S.A.8
Chartash, E.K.9
-
5
-
-
25444517037
-
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment
-
British Thoracic Society Standards of Care Committee
-
British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment. Thorax 2005;60(10):800-5.
-
(2005)
Thorax
, vol.60
, Issue.10
, pp. 800-805
-
-
-
6
-
-
64749087194
-
Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold in Tube assay, and T-Spot.TB test in contact investigations for tuberculosis
-
Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009;135:1010-18.
-
(2009)
Chest
, vol.135
, pp. 1010-1018
-
-
Diel, R.1
Loddenkemper, R.2
Meywald-Walter, K.3
-
8
-
-
0036169930
-
Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: Comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis
-
Pablos JL. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis. Arthritis Rheum 2002;46:328-46.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 328-346
-
-
Pablos, J.L.1
-
10
-
-
33747336276
-
Infliximab for rheumatoid arthritis in a patient with tuberculosis
-
Matsumoto T, Tanaka T, Kawase I. Infliximab for rheumatoid arthritis in a patient with tuberculosis. N Engl J Med 2006;355:740-1.
-
(2006)
N Engl J Med
, vol.355
, pp. 740-741
-
-
Matsumoto, T.1
Tanaka, T.2
Kawase, I.3
-
11
-
-
38149011457
-
Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?
-
Aslanidis S, Pyrpasopoulou A, Douma S, et al. Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare? Arthritis Rheum 2008;58:327-8.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 327-328
-
-
Aslanidis, S.1
Pyrpasopoulou, A.2
Douma, S.3
-
12
-
-
52049086818
-
Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes
-
Blackmore TK, Manning L, Taylor WJ, et al. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008;47:e83-5.
-
(2008)
Clin Infect Dis
, vol.47
-
-
Blackmore, T.K.1
Manning, L.2
Taylor, W.J.3
|